Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome.
Marumo A, Nagata Y, Fujioka M, Kurosawa S, Najima Y, Sakaida E, Doki N, Fukushima K, Ota S, Shono K, Ito A, Uchida N, Nishida T, Sawa M, Tsunemine H, Matsuoka KI, Makoto O, Kanda Y, Fukuda T, Atsuta Y, Itonaga H. Marumo A, et al. Among authors: fujioka m. Cytotherapy. 2025 Feb;27(2):222-228. doi: 10.1016/j.jcyt.2024.09.006. Epub 2024 Oct 17. Cytotherapy. 2025. PMID: 39503682
Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy.
Konuma T, Itonaga H, Shimomura Y, Fujioka M, Aoki K, Uchida N, Onizuka M, Jinguji A, Tanaka M, Ueda Y, Katayama Y, Sawa M, Tanaka H, Nakamae H, Kawakita T, Maruyama Y, Takahashi S, Ishimaru F, Kanda J, Ichinohe T, Atsuta Y. Konuma T, et al. Among authors: fujioka m. Hematol Oncol. 2024 Jan;42(1):e3217. doi: 10.1002/hon.3217. Epub 2023 Aug 18. Hematol Oncol. 2024. PMID: 37592904
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy.
Itonaga H, Miyazaki Y, Fujioka M, Aoki J, Doki N, Nishida T, Fukuda T, Uchida N, Ueda Y, Uehara Y, Katayama Y, Ota S, Kawakita T, Kato J, Matsuoka KI, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Ishiyama K. Itonaga H, et al. Among authors: fujioka m. Bone Marrow Transplant. 2024 Aug;59(8):1107-1117. doi: 10.1038/s41409-024-02297-0. Epub 2024 May 7. Bone Marrow Transplant. 2024. PMID: 38714756
Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy.
Itonaga H, Fukushima T, Kato K, Nakano N, Kato T, Tanaka T, Eto T, Mori Y, Kawakita T, Uchida N, Fujioka M, Nakamae H, Ogata M, Morishima S, Fukuda T, Kanda Y, Atsuta Y, Fuji S, Yoshimitsu M. Itonaga H, et al. Among authors: fujioka m. Hematol Oncol. 2024 Nov;42(6):e3315. doi: 10.1002/hon.3315. Hematol Oncol. 2024. PMID: 39367543
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT.
Fujioka M, Itonaga H, Nakazawa H, Nishida T, Kataoka K, Ikeda T, Kako S, Matsuoka KI, Adachi K, Fujiwara SI, Aotsuka N, Kawakita T, Sakaida E, Kanda Y, Ichinohe T, Atsuta Y, Miyazaki Y, Ishiyama K. Fujioka M, et al. Transplant Cell Ther. 2025 Jan;31(1):18.e1-18.e12. doi: 10.1016/j.jtct.2024.09.026. Epub 2024 Oct 6. Transplant Cell Ther. 2025. PMID: 39374663
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
Sakamoto H, Itonaga H, Sawayama Y, Furumoto T, Fujioka M, Chiwata M, Toriyama E, Kasai S, Nakashima J, Horai M, Kato T, Sato S, Ando K, Taguchi J, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Miyazaki Y. Sakamoto H, et al. Among authors: fujioka m. Hematol Oncol. 2020 Apr;38(2):162-170. doi: 10.1002/hon.2712. Epub 2020 Jan 26. Hematol Oncol. 2020. PMID: 31922287
Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki Transplant Group Experience.
Fujioka M, Itonaga H, Furumoto T, Sakaki C, Sakamoto H, Kato T, Horai M, Taguchi M, Sawayama Y, Taguchi J, Imaizumi Y, Yoshida S, Moriuchi Y, Miyazaki Y. Fujioka M, et al. Transpl Immunol. 2022 Dec;75:101707. doi: 10.1016/j.trim.2022.101707. Epub 2022 Sep 8. Transpl Immunol. 2022. PMID: 36087807
Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement.
Kato T, Itonaga H, Taguchi J, Makiyama J, Fujioka M, Taguchi M, Horai M, Sawayama Y, Niino D, Imaizumi Y, Hata T, Yoshida S, Sakamoto K, Takeuchi K, Ohshima K, Miyazaki Y. Kato T, et al. Among authors: fujioka m. Leuk Res Rep. 2019 Apr 22;11:31-33. doi: 10.1016/j.lrr.2019.04.005. eCollection 2019. Leuk Res Rep. 2019. PMID: 31061790 Free PMC article.
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
Kasai S, Itonaga H, Niino D, Miyoshi H, Kato T, Imanishi D, Fujioka M, Furumoto T, Sato S, Sawayama Y, Taguchi J, Imaizumi Y, Hata T, Yoshida S, Moriuchi Y, Ohshima K, Miyazaki Y. Kasai S, et al. Among authors: fujioka m. Int J Hematol. 2020 Oct;112(4):524-534. doi: 10.1007/s12185-020-02926-6. Epub 2020 Jun 25. Int J Hematol. 2020. PMID: 32588395
High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.
Itonaga H, Kato T, Fujioka M, Taguchi M, Taniguchi H, Imaizumi Y, Yoshida S, Miyoshi H, Moriuchi Y, Ohshima K, Miyazaki Y. Itonaga H, et al. Among authors: fujioka m. Intern Med. 2017;56(14):1873-1877. doi: 10.2169/internalmedicine.56.7938. Epub 2017 Jul 15. Intern Med. 2017. PMID: 28717085 Free PMC article.
867 results